Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$1.29
—
Mkt Cap $217.02M
Analyst Ratings
Buy
1
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
Implied Upside
+1170.8%
Consensus $16.33 vs current $1.29
NASDAQ·Healthcare·Biotechnology
$1.29
—
Mkt Cap $217.02M
Buy
1
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
+1170.8%
Consensus $16.33 vs current $1.29